(MRSH) Marsh & McLennan Companies - NYSE
Sector: Financial Services | Industry: Insurance Brokers | Exchange: NYSE (USA) | Market Cap: 77.694m USD | Total Return: -22.8% in 12m
Avg Turnover: 441M
EPS Trend: 97.4%
Qual. Beats: 0
Rev. Trend: 99.8%
Warnings
Fakeout Below Avwap Earnings
Tailwinds
No distinct edge detected
Marsh & McLennan Companies, Inc. (NYSE: MMC) is a global professional services firm specializing in risk, strategy, and human capital. The company operates through two primary divisions: Risk and Insurance Services and Consulting. Its business model relies on a diversified fee-based structure, providing risk management, insurance brokerage, and actuarial services to corporate and public sector clients.
The insurance brokerage sector acts as a critical intermediary between businesses and carriers, often benefiting from increased demand during periods of heightened economic or geopolitical volatility. Marsh & McLennan maintains one of the largest market shares in this industry, leveraging data analytics and proprietary modeling to manage complex global insurance programs. The consulting segment further diversifies revenue by providing specialized management and workforce advisory services.
For a detailed analysis of the companys valuation and growth metrics, consider reviewing the latest data on ValueRay.
- Rising commercial insurance premium rates drive higher brokerage commission revenue
- Global economic growth volatility impacts demand for strategic and human capital consulting
- Strategic acquisitions of regional brokerages accelerate inorganic revenue and market share growth
- Interest rate fluctuations influence fiduciary interest income and pension consulting liabilities
- Corporate risk exposure complexity increases demand for specialized reinsurance and analytical services
| Net Income: 3.92b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -0.09 > 1.0 |
| NWC/Revenue: 7.91% < 20% (prev 10.72%; Δ -2.82% < -1%) |
| CFO/TA 0.09 > 3% & CFO 5.23b > Net Income 3.92b |
| Net Debt (22.7b) to EBITDA (6.68b): 3.40 < 3 |
| Current Ratio: 1.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (486.0m) vs 12m ago -1.82% < -2% |
| Gross Margin: 42.37% > 18% (prev 42.60%; Δ -0.23% > 0.5%) |
| Asset Turnover: 47.62% > 50% (prev 43.93%; Δ 3.69% > 0%) |
| Interest Coverage Ratio: 6.03 > 6 (EBIT TTM 5.75b / Interest Expense TTM 955.0m) |
| A: 0.04 (Total Current Assets 23.2b - Total Current Liabilities 21.1b) / Total Assets 58.6b |
| B: 0.48 (Retained Earnings 28.0b / Total Assets 58.6b) |
| C: 0.10 (EBIT TTM 5.75b / Avg Total Assets 57.8b) |
| D: 0.33 (Book Value of Equity 14.6b / Total Liabilities 43.7b) |
| Altman-Z'' = 2.82 = A |
| DSRI: 0.97 (Receivables 8.43b/7.87b, Revenue 27.5b/25.0b) |
| GMI: 1.01 (GM 42.60% / 42.37%) |
| AQI: 1.00 (AQ_t 0.56 / AQ_t-1 0.57) |
| SGI: 1.10 (Revenue 27.5b / 25.0b) |
| TATA: -0.02 (NI 3.92b - CFO 5.23b) / TA 58.6b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of June 20, 2026, the stock is trading at USD 162.41 with a total of 4,188,300 shares traded.
Over the past week, the price has changed by -3.41%,
over one month by -2.15%,
over three months by -4.55% and
over the past year by -22.77%.
Marsh & McLennan Companies has received a consensus analysts rating of 3.61. Therefore, it is recommended to hold MRSH.
- StrongBuy: 6
- Buy: 3
- Hold: 13
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 199.6 | 22.9% |
P/E Trailing = 20.1323
P/E Forward = 15.873
P/S = 2.8233
P/B = 5.4307
P/EG = 1.5867
Revenue TTM = 27.5b USD
EBIT TTM = 5.75b USD
EBITDA TTM = 6.68b USD
Long Term Debt = 18.9b USD (from longTermDebt, last quarter)
Short Term Debt = 2.03b USD (from shortTermDebt, last quarter)
Debt = 24.3b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.85b
Net Debt = 22.7b USD (calculated: Debt 24.3b - CCE 1.61b)
Enterprise Value = 100b USD (77.7b + Debt 24.3b - CCE 1.61b)
Interest Coverage Ratio = 6.03 (Ebit TTM 5.75b / Interest Expense TTM 955.0m)
EV/FCF = 19.91x (Enterprise Value 100b / FCF TTM 5.04b)
FCF Yield = 5.02% (FCF TTM 5.04b / Enterprise Value 100b)
FCF Margin = 18.32% (FCF TTM 5.04b / Revenue TTM 27.5b)
Net Margin = 14.26% (Net Income TTM 3.92b / Revenue TTM 27.5b)
Gross Margin = 42.37% ((Revenue TTM 27.5b - Cost of Revenue TTM 15.9b) / Revenue TTM)
Gross Margin QoQ = 45.64% (prev 40.29%)
Tobins Q-Ratio = 1.71 (Enterprise Value 100b / Total Assets 58.6b)
Interest Expense / Debt = 3.93% (Interest Expense 955.0m / Debt 24.3b)
Taxrate = 24.28% (1.28b / 5.29b)
NOPAT = 4.36b (EBIT 5.75b * (1 - 24.28%))
Current Ratio = 0.92 (Total Current Assets 23.2b / Total Current Liabilities 25.2b)
Debt / Equity = 1.67 (Debt 24.3b / totalStockholderEquity, last quarter 14.6b)
Debt / EBITDA = 3.40 (Net Debt 22.7b / EBITDA 6.68b)
Debt / FCF = 4.50 (Net Debt 22.7b / FCF TTM 5.04b)
Total Stockholder Equity = 15.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.79% (Net Income 3.92b / Total Assets 58.6b)
RoE = 25.91% (Net Income TTM 3.92b / Total Stockholder Equity 15.1b)
RoCE = 16.90% (EBIT 5.75b / Capital Employed (Equity 15.1b + L.T.Debt 18.9b))
RoIC = 7.62% (NOPAT 4.36b / Invested Capital 57.2b)
WACC = 5.41% (E(77.7b)/V(102b) * Re(6.17%) + D(24.3b)/V(102b) * Rd(3.93%) * (1-Tc(0.24)))
Discount Rate = 6.17% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.45 | Cagr: -1.08%
[DCF] Terminal Value 75.65% ; FCFF base≈5.01b ; Y1≈5.10b ; Y5≈5.54b
[DCF] Fair Price = 131.4 (EV 86.0b - Net Debt 22.7b = Equity 63.3b / Shares 481.8m; r=8.35% [WACC [floored]]; 5y FCF grow 1.59% → 2.50% )
EPS Correlation: 97.36 | EPS CAGR: 9.16% | SUE: 0.83 | # QB: 0
Revenue Correlation: 99.77 | Revenue CAGR: 9.04% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.90 | Chg30d=-0.26% | Revisions=-62% | Analysts=21
EPS next Quarter (2026-09-30): EPS=1.98 | Chg30d=+0.27% | Revisions=+6% | Analysts=21
EPS current Year (2026-12-31): EPS=10.40 | Chg30d=+0.00% | Revisions=+22% | GrowthEPS=+6.7% | GrowthRev=+5.4%
EPS next Year (2027-12-31): EPS=11.32 | Chg30d=+0.00% | Revisions=+18% | GrowthEPS=+8.8% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: -62%